| Literature DB >> 28962449 |
Aparamita Pandey1, Medhamurthy Rudraiah1.
Abstract
The effect of Roundup® on adrenal gland steroidogenesis and signaling pathway associated with steroid production was investigated. Doses of 10, 50, 100 and 250 mg/kg bw/d Roundup® were administered for two weeks to adult male rats. The 10 mg/kg bw/d dose which reduced circulatory corticosterone levels, but did not change food consumption and body weight, was selected for further study. The expression of cholesterol receptor (low density lipoprotein receptor), de novo cholesterol synthesis enzyme (3-hydroxy-3-methylglutaryl-coenzyme A synthase), hormone-sensitive lipase, steroidogenic acute regulatory protein (StAR) mRNA and phosphorylated form was decreased. Adrenocorticotropic hormone receptor (ACTH), melanocortin-2 receptor, expression was not changed but circulatory ACTH levels and adrenal cortex protein kinase A (PKA) activity were reduced. Surprisingly, exogenous ACTH treatment rescued steroidogenesis in Roundup®-treated animals. Apoptosis was evident at 250 mg/kg bw/d, but not at 10 mg/kg bw/d dose. These results suggest that Roundup® may be inhibitory to hypothalamic-pituitary axis leading to reduction in cyclic adenosine monophosphate (cAMP)/PKA pathway, StAR phosphorylation and corticosterone synthesis in the adrenal tissue.Entities:
Keywords: ACTH, adrenocorticotropic hormone; Adrenal gland; Creb, cAMP response element-binding protein; DAPI, 4′,6-diamidino-2-phenylindole; DPX, distrene, plasticiser, xylene; EDC, endocrine disrupting chemical; EDTA, ethylenediaminetetraacetate; EGTA, ethylene glycol tetraacetate; EIA, enzyme Immunoassay; ELISA, enzyme-linked immunosorbent assay; Endocrine disruptor; Glyphosate; Hmgcr, 3-hydroxy-3-methylglutaryl-CoA reductase; Hmgcs, 3-hydroxy-3-methylglutaryl-coenzyme A synthase; Hsl, hormone-sensitive lipase; L:D cycle, light–dark cycle; LD50, lethal dose, 50%; Ldlr, low density lipoprotein receptor; Mc2r, melanocortin-2 receptor; PBS, phosphate buffer saline; PKA, protein kinase A; RIA, radioimmunoassay; RIPA buffer, radioimmunoprecipitation assay buffer; Rat; SD, standard deviation; SDS PAGE, sodium dodecyl sulfate polyacrylamide gel electrophoresis; Sr-b1, scavenger receptor class B member 1; StAR; StAR, steroidogenic acute regulatory protein; Steroidogenesis; TUNEL, terminal deoxynucleotidyl transferase dUTP nick end labeling; TdT, terminal deoxynucleotidyl transferase; cAMP, cyclic adenosine monophosphate; qPCR, quantitative real-time PCR; β ME, beta mercaptoethanol
Year: 2015 PMID: 28962449 PMCID: PMC5598379 DOI: 10.1016/j.toxrep.2015.07.021
Source DB: PubMed Journal: Toxicol Rep ISSN: 2214-7500
List of primers used for qPCR analysis.
| Gene | NCBI gene ID | Forward primer (5′3′) | Reverse primer (3′5′) |
|---|---|---|---|
| Rpl19 | 81767 | CGTCCTCCGCTGTGGTAAA | AGTACCCTTCCTCTTCCCTATGC |
| Srb1 | 25073 | TGGGATGAACGACTCGAGT | AGTACCATTGATCATGTTGCAC |
| Ldlr | 300438 | GAGTCCCCTGAGACATGCAT | GGGAGCAGTCTAGTTCATCCG |
| Hmgcr | 25675 | GGGTCAAGATGATCATGTCT | ATTCTCTTGGACACATCTTCAG |
| Hmgcs | 29637 | ACGATACGCTTTGGTAGTTG | AAGCCCTCGGTCAAAAAT |
| Hsl | 25330 | CCTGCAACAGAGACACTGC | CTCTGAGTTGCCCTTAAAGCTC |
| P450SCC | 29680 | ACCCAACTCGTTGGTTGGA | CACGTTGATGAGGAAGATGGT |
| StAR | 25557 | GGCCCCGAGACTTCGTAA | TGGCAGCCACCCCTTGA |
| Mc2r | 282839 | GTCCCCCGTGTACTTTTTCATC | GGACGAACATGCAGTCAATGAT |
(A) Average food consumption (g) per animal per day and (B) body weight (g) during Roundup® treatment.
| (A) | |||||
|---|---|---|---|---|---|
| Days of treatment | Control | 10 mg/kg bw/d | 50 mg/kg bw/d | 100 mg/kg bw/d | 250 mg/kg bw/d |
| 0–3 | 16.75 ± 1.2 | 16.3 ± 1.5 | 16.7 ± 0.4 | 16.1 ± 1.3 | 14.3 ± 2.1 |
| 4–7 | 21.6 ± 1.8 | 19.9 ± 1.6 | 18.55 ± 0.12 | 15.2 ± 1.04 | 13.03 ± 0.8 |
| 8–11 | 22.4 ± 1.9 | 20.2 ± 1.8 | 19.15 ± 0.6 | 13.5 ± 1.08 | 11.8 ± 0.4 |
| 12–15 | 23.19 ± 1.9 | 20.3 ± 1.7 | 18.4 ± 0.8 | 12.8 ± 1.1 | 11.7 ± 0.4 |
Values are mean ± SEM. Vehicle group received milliQ water for 14 days and other groups administered with different doses of Roundup® for 14 days. Statistical significance from vehicle group was determined by two way ANOVA followed by Bonferroni test.
p < 0.05.
p < 0.01.
p < 0.001.
Fig. 1Circulatory hormone levels in vehicle and Roundup®-treated animals. Male rats were treated orally with vehicle, 10 and 50 mg/kg bw/d Roundup® for 14 days. Circulatory corticosterone (A) and testosterone (B) levels were measured at the end of 14 days treatment. Data are presented as mean ± SEM (n = 5 per group). ‘t’ test was performed to compare each treatment group to the vehicle group. *, ***, significantly different from vehicle group by p < 0.05, 0.0001 viz.
Fig. 2Expression of steroidogenic genes in vehicle and Roundup®-treated rats. Male rats were treated orally with vehicle or 10 mg/kg bw/d Roundup® for 14 days. Total RNA from adrenal gland was isolated and qPCR analysis was performed to quantitate the fold change of P450scc (A) and StAR gene expression (B). Rpl19 was used as internal control. The mRNA expression value in vehicle treated animals was set as 1 fold and the mRNA expression value of the treated group was expressed in relation to the vehicle group. Immunoblot analysis of total and phosphorylated form of StAR and CREB proteins (C and D) was performed using the adrenal gland protein lysate from vehicle and Roundup®-treated rats. Immunoblot densitometry arbitrary values for vehicle group was set as fold 1 and the values in treated groups were represented compare in comparison to the vehicle group. Blots are representative of three or more experiments. Values are presented as mean ± SEM (n = 5 per group). ‘t’ test was performed to compare each treatment group with vehicle group. *, **, ***, significantly different from vehicle group by p < 0.05, 0.01, 0.001.
Fig. 3Plasma cholesterol and lipoprotein levels in vehicle and Roundup®-treated animals. Plasma from control and treatment group were collected and subjected to total, free, esterified cholesterol analysis and HDL, LDL measurement. Values are presented as mean ± SEM (n = 3–4 per group). ‘t’ test was performed to compare each treatment group with vehicle group. *,**, p < 0.05, p < 0.01 viz.
Fig. 4Total cholesterol levels in adrenal gland lysate (A) of vehicle and Roundup®-treated group. The adrenal glands were weighed (B), sectioned and stained for H&E (C) and ORO (D) post Roundup® treatment. Sections are representative of two or more runs. Values are presented as mean ± SEM (n = 3–5 per group). ‘t’ test was performed to compare each treatment group with vehicle group. *, p < 0.05.
Fig. 5Expression of genes associated with cholesterol import and de novo synthesis in the adrenal gland of vehicle and Roundup®-treated animals. qPCR analysis was performed to quantitate the expression of genes involved in cholesterol transport (Srb1, Ldlr) (A and B) and Cholesterol de novo synthesis (Hmgcr, Hmgcs) (C and D). Rpl19 was used as internal control. mRNA expression in the vehicle treated group was set as 1 fold and the expression in treatment group was calculated in relation to the vehicle group. Data presented as mean ± SEM (n = 5 rats per group). ‘t’ test was performed to compare treatment group from vehicle group. *, significantly different from the vehicle group (p < 0.05).
Fig. 6Esterified cholesterol levels (A) of adrenal gland from vehicle and 10 mg/kg bw/d Roundup®-treated animals. Adrenal glands were isolated post treatment and lysate was prepared. Esterified cholesterol levels were obtained by subtracting free cholesterol levels from total cholesterol values. qPCR was performed to detect Hsl gene expression in the adrenal gland of vehicle and 10 mg/kg bw/d Roundup®-treated animals (B). Rpl19 was used as internal control. qPCR value for vehicle was set as 1 fold and Roundup®-treated group values were plotted in relation to the vehicle treated group. Values are presented in mean ± SEM (n = 6 rats per group). ‘t’ test was performed to compare the two groups.
Fig. 7Dose dependent adrenal ACTH receptor expression (A) and circulatory ACTH levels (B) present in vehicle and Roundup®-treated animals. Blood plasma was collected and ACTH levels were measure utilizing luminescence based assay kit. ACTH receptor, Mc2r, expression was examined by qPCR analysis. Rpl19 was used as internal control. Vehicle group values were set as one fold and values in the treated groups were expressed in relation to the vehicle group. One way ANOVA was performed to compare the vehicle group with the treatment groups.
Fig. 8Circulatory corticosterone levels in ACTH administered and/or vehicle and Roundup®-treated groups. Animals were treated with vehicle and Roundup® (10 mg/kg bw/d). 5 IU of porcine ACTH was administered intravenously. Post 1 h of ACTH treatment, corticosterone levels were measured in the plasma. Data presented as mean ± SEM (n = 3–4 rats per group). ‘t’ test was performed to compare vehicle and treatment groups. *, ** & ***, significantly different from the vehicle group by p < 0.05. p < 0.01, p < 0.001 viz.
Fig. 9Expression of StAR and genes associated with cholesterol homeostasis post vehicle, Roundup® and/or ACTH treatments. qPCR analysis was performed for StAR (A), Hsl (B), cholesterol homeostasis related genes, Srb1, Ldlr, Hmgcr, Hmgcs (D–G). The cortical region lysate was utilized to quantitate PKA activity (C). Values are presented as mean ± SEM (n = 3–4 rats per group). ‘t’ test was performed to calculate significance between treatment and vehicle groups. *, ** & ***, significantly different from the vehicle group by p < 0.05, p < 0.01, p < 0.001 viz.
Fig. 10Schematic representation of EDC mechanism of glyphosate formulation on adrenal gland steroidogenesis under in vivo condition. Roundup® appears to act at HPA axis to down regulate endogenous ACTH levels which in turn down regulates cAMP/PKA pathway. Lowered activity of PKA leads to down regulation in CREB and StAR phosphorylation, leading to down regulation of StAR function and steroidogenesis.